DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Bethesda North Marriott Hotel and Conference Center

2014年3月18日 (火) 午前 8:30 - 2014年3月20日 (木) 午後 4:00

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Beginning with the End in Mind – Study Endpoints: Targeting Patient-Centered Outcomes

Recap of Morning Session and Introduction to Afternoon Session: Measurement to Achieve Labeling and Promotion Claims

Session Chair(s)

Linda S. Deal, MS

Linda S. Deal, MS

Head of Patient-Centered Outcomes Measurement

Pfizer Inc., United States

Elektra  Papadopoulos, MD, MPH

Elektra Papadopoulos, MD, MPH

Director, Patient Experience Data and Strategy

AbbVie, United States

Good measurement principles form the foundation for clinical outcome measurement. Investment in measurement will ultimately benefit people with diseases, drug developers, clinical trialists, and regulatory authorities. This session will provide an overview of the comprehensive process of creating and implementing a new outcome measure or modifying an existing instrument. The development of a patient-based, clinical outcome measure that will support a labelling claim requires advance planning in the early phases of product development. Establishing the context of use and planning the protocol for qualitative research that thoroughly explores the conceptual basis for measurement are fundamental. This session emphasizes the importance of identifying what is meaningful to be measured based on the context of use for measurement, getting the content right, and finally, ensuring that the measure is meaningful and interpretable.

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。